Roots Analysis
JANUARY 28, 2024
Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? His work provides insight into AI and big data in relation to pharma and drug discovery– now and in the future. “AI Up front collection and controlling your data! Key opportunties.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JULY 11, 2023
Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. This knowledge enabled cell line engineering campaigns that boosted yield and stability across various production bottlenecks.
Drug Discovery World
FEBRUARY 6, 2024
Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used an AI target discovery engine to analyse transcriptomic data to identify dual targets for cancer and ageing 5.
Pharma Marketing Network
NOVEMBER 11, 2020
Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. These changes include marketing processes, customer engagement, tools and tactics. .
pharmaphorum
FEBRUARY 1, 2022
David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. He is also a research fellow of the Royal Academy of Engineering and a fellow of the Alan Turing Institute. Since 2008, he has translated his work into the biomedical context for healthcare applications.
Drug Discovery World
DECEMBER 20, 2022
As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. . There will be greater emphasis on diversity in clinical trials. M&A activity will accelerate.
Expert insights. Personalized for you.
40 
Let's personalize your content